Yuval Cohen
CEO
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Chief Executive Officer | $646,566 | $3,750,125 |
| 2024 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Chief Executive Officer | $621,883 | $4,245,438 |
| 2023 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Chief Executive Officer | $598,850 | $1,137,622 |
| 2022 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Chief Executive Officer | $598,071 | $1,442,841 |
| 2021 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Chief Executive Officer | $578,675 | $4,858,306 |
Executive changes
Earnings-call appearances
-
Jefferies Global Healthcare Conference2026-06-04
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
-
Pre-2026 ASCO Conference Call & Webcast2026-05-26
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
-
Corbus Pharmaceuticals Holdings, Inc. Q4 FY2020 Earnings Call2021-03-15
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
-
Corbus Pharmaceuticals Holdings, Inc. Q3 FY2020 Earnings Call2020-11-10
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
-
Corbus Pharmaceuticals Holdings, Inc. Q2 FY2020 Earnings Call2020-08-06
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
-
Corbus Pharmaceuticals Holdings, Inc. Q1 FY2020 Earnings Call2020-05-11
Corbus Pharmaceuticals Holdings, Inc. (CRBP)